Sep 6, 2026 at 5:42 AM
•
$827.72
(-1.87%)
Regeneron Pharmaceuticals Inc (REGN) fell 1.87% to finish at $827.72 on September 6.
From a technical standpoint, the outlook appears bullish:
Moving Averages
Price trades above the 9-day EMA ($825.45) with a bullish stack. The 21-day EMA at $805.84 provides support.
Momentum
RSI at 60.9 is neutral but improving. MACD reads 25.39 against its 28.77 signal line (bearish).
Volatility
Stock has been in a TTM Squeeze for 4 days, indicating compressed volatility and potential for a significant move.
While the trend remains bullish, weakening MACD warrants caution for new entries at current levels.
Support sits at $784.04 with resistance at $851.47.